Solid Biosciences Stock Drops 4% Due To Wider Loss In Q4
(RTTNews) - Stock of Solid Biosciences Inc. (SLDB) is moving down over 4 percent on Wednesday morning following the announcement of an increase in loss in the fourth-quarter.
The company's loss increased to $20.3 million, from $15.2 million primarily due to increased yields on cash equivalents and available-for-sale securities, offsetting gain on acquisition and collaboration revenue in 2022.
Currently, the life sciences company's stock is falling 4.65 percent, to $10.87 over the previous close of $11.40 on the Nasdaq.
The stock has traded between $1.81 and $12.20 in the past 52-week period.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.